Epithelial to mesenchymal transition: a mechanism that fuels cancer radio/chemoresistance

J Dudás, A Ladányi, J Ingruber, TB Steinbichler… - Cells, 2020 - mdpi.com
Epithelial to mesenchymal transition (EMT) contributes to tumor progression, cancer cell
invasion, and therapy resistance. EMT is regulated by transcription factors such as the …

Tissue transglutaminase: A multifunctional and multisite regulator in health and disease

Z Yao, Y Fan, L Lin, RE Kellems… - Physiological …, 2024 - journals.physiology.org
Tissue transglutaminase (TG2) is a widely distributed multifunctional protein involved in a
broad range of cellular and metabolic functions carried out in a variety of cellular …

Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes

K Miyabayashi, LA Baker, A Deschênes, B Traub… - Cancer discovery, 2020 - AACR
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal common malignancy, with little
improvement in patient outcomes over the past decades. Recently, subtypes of pancreatic …

Versatility of microbial transglutaminase

P Strop - Bioconjugate chemistry, 2014 - ACS Publications
Although microbial transglutaminases (mTGs) were initially discovered to offset the cost of
producing mammalian transglutaminases for food applications, they have quickly become …

Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance

M Najafi, B Farhood, K Mortezaee… - Journal of cancer …, 2020 - Springer
Abstract Purpose Cancer stem cells (CSCs) are highly tumorigenic cell types that reside
within specific areas of tumor microenvironment (TME), and are endowed with self-renewal …

Bioorthogonal labeling and enrichment of histone monoaminylation reveal its accumulation and regulatory function in cancer cell chromatin

N Zhang, J Wu, F Hossain, H Peng, H Li… - Journal of the …, 2024 - ACS Publications
Histone monoaminylation (ie., serotonylation and dopaminylation) is an emerging category
of epigenetic mark occurring on the fifth glutamine (Q5) residue of H3 N-terminal tail, which …

The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma

RJ Wordinger, T Sharma, AF Clark - Journal of Ocular …, 2014 - liebertpub.com
Primary open-angle glaucoma (POAG) is the second leading cause of blindness worldwide.
Elevated intraocular pressure (IOP) is a primary risk factor associated with POAG. Increased …

[HTML][HTML] SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes

L Zeng, W Zheng, X Liu, Y Zhou, X Jin, Y Xiao, Y Bai… - Theranostics, 2023 - ncbi.nlm.nih.gov
Rationale: Glioblastoma (GBM) is the most common and malignant primary brain tumor in
adults. Radiotherapy has long been an important treatment for GBM. Despite recent …

Transglutaminase is a tumor cell and cancer stem cell survival factor

RL Eckert, ML Fisher, D Grun, G Adhikary… - Molecular …, 2015 - Wiley Online Library
Recent studies indicate that cancer cells express elevated levels of type II transglutaminase
(TG2), and that expression is further highly enriched in cancer stem cells derived from these …

[HTML][HTML] PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis

O Karicheva, JM Rodriguez-Vargas, N Wadier… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Several members of the Poly (ADP-ribose) polymerase (PARP) family are essential
regulators of genome integrity, actively prospected as drug targets for cancer therapy …